Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.0491
-0.0019 (-3.73%)
Sep 5, 2025, 12:48 PM - Market open
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $13.01 million as of September 5, 2025. Its market cap has decreased by -95.46% in one year.
Market Cap
13.01M
Enterprise Value
36.14M
1-Year Change
-95.46%
Ranking
Category
Stock Price
$0.05
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $13.01M, a decrease of -97.74%. That is a compound annual growth rate of -33.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 13.50M | -90.21% |
| Dec 31, 2024 | 137.90M | -23.43% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
| Mar 31, 2016 | 575.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |